Stretch Marks Treatment Market Outlook:
Stretch Marks Treatment Market size was valued at USD 3.12 billion in 2024 and is projected to reach USD 5.75 billion by the end of 2037, rising at a CAGR of 4.8% during the forecast period, 2025 to 2037. In 2025, the industry size of stretch marks treatment is estimated at USD 3.27 billion.
The prominent patient base for the stretch mark treatment includes post-partum women. According to the National Health Service, almost 81% of pregnant women experience striae distensae. Various devices, such as fractional CO2 lasers, require clearance from the FDA under medical device premarket clearance. This shapes landscape compliance throughout the distribution and manufacturing stages. The dynamics for the export and import need to align with the wider regulatory framework under the U.S. Customs and Border Protection. Device components and APIs are subject to strict entry controls before entering the supply chain.
The insights obtained from the U.S. Consumer Price Index (CPI) and Producer Price Index (PPI) for the pharmaceuticals and medical supplies provider suggest controlled inflation during 2022-2024. The research and development in the development of products and devices is increasing with the surge in demand. The supply chain rigor and plethora of investment trends confirm the positioning of the market and compliance strategy in the context of B2B. Also, the supply chain for the market is evolving with the advent of trends such as AI-enabled treatment and customized skincare.
